BioWorld - Tuesday, July 28, 2026 See today's BioWorld Home Microbiota modulates the antidepressant effects of GLP-1 analogues Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on the GLP-1 receptor but instead on the gut microbiota, since the treatment increases the presence of the bacterium Lactobacillus delbrueckii
This condition affects the peripheral nerves, which may cause numbness, tingling, burning sensations, or difficulty with coordination and balance
But constipation on the road is a problem nobody talks about
For D50.0 (iron deficiency secondary to blood loss), link the anemia to the bleeding source
Ethics declarations Ethics approval and consent to participate The animal protocol for this study was approved by the Institutional Animal Care and Use Committee of Huazhong Agricultural University, China (HZAURA-2025-0001)
Bangladesh Journal of Pharmacology 10: 152-159
